Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?

Pharmacoepidemiology and Drug Safety
Gillian E CaugheyAndrew L Gilbert

Abstract

To examine the prescribing of prochlorperazine secondary to the prescribing of a medicine which could lead to symptoms for which prochlorperazine is indicated and commonly used. Given the range of potential hypotensive, sedative, dystonic and other extra-pyramidal side effects associated with prochlorperazine, its association with hip fracture was also examined. Prescription/event sequence symmetry analyses were undertaken from 1st January 2003 to 31st December 2006, using administrative claims data from the Department of Veterans' Affairs, Australia. This method assesses asymmetry in the distribution of an incident event (either prescription of another medicine or hospitalization) before and after the initiation of prochlorperazine. Crude and adjusted sequence ratios (ASR) with 95% confidence intervals (CI) were calculated. A total of 34 235 persons with incident use of prochlorperazine were identified during the study period. Statistically significant positive associations were found for a number of commonly used medicines, including cardiovascular medicines, NSAIDs, opioids and sedatives and the subsequent initiation of prochlorperazine that ranged from 1.07 (95%CI 1.01-1.14) for diuretics to 1.50 (95%CI 1.40-1.61) for stati...Continue Reading

References

Nov 21, 1997·BMJ : British Medical Journal·P A Rochon, J H Gurwitz
Sep 28, 1999·Annals of Emergency Medicine·D L Drotts, D R Vinson
Oct 20, 1999·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·K M SandersM A Kotowicz
Nov 9, 2000·Alimentary Pharmacology & Therapeutics·P Bytzer, J Hallas
Mar 20, 2003·Naunyn-Schmiedeberg's Archives of Pharmacology·Wei-Qing RangYuan-Jian Li
Feb 10, 1963·Svensk farmaceutisk tidskrift·N DIDING
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·G Lindberg, J Hallas
Jun 8, 2004·International Journal of Clinical Pharmacology and Therapeutics·W HimmelE Hummers-Pradier
Oct 18, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Julie A PascoMark A Kotowicz
Jul 5, 2006·Pharmacoepidemiology and Drug Safety·Louise SilwerCecilia Stålsby Lundborg
Feb 17, 2007·Lancet Neurology
Jun 15, 2007·Lancet·Jane Armitage
Sep 14, 2007·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Anne HassettBrad Smith
Mar 15, 2008·BMJ : British Medical Journal·James C MiltonStephen H D Jackson
Jan 22, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S PouwelsF de Vries
Feb 25, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Wilbert S Aronow
Mar 11, 2009·The Medical Clinics of North America·Ronald J Tusa
Mar 28, 2009·Pharmacoepidemiology and Drug Safety·Ioannis TsiropoulosJesper Hallas
Apr 18, 2009·The American Journal of Emergency Medicine·Michael A MillerAlex Rosin
Jul 28, 2009·QJM : Monthly Journal of the Association of Physicians·D ScottG Jones
Aug 28, 2009·Australian Dental Journal·UNKNOWN Australian Research Centre for Population Oral Health, The University of Adelaide, South Australia
Oct 8, 2009·American Journal of Epidemiology·Suzanne E BentlerFredric D Wolinsky

❮ Previous
Next ❯

Citations

Sep 11, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Ellen Melbye LangballeGeir Selbæk
Apr 5, 2011·The American Journal of Geriatric Pharmacotherapy·Emily P PeronSteven M Handler
Feb 16, 2013·Pharmacoepidemiology and Drug Safety·Izyan A WahabElizabeth E Roughead
Aug 16, 2013·Pharmacoepidemiology and Drug Safety·Edward Chia-Cheng LaiCheng-Yang Hsieh
Mar 19, 2014·Journal of the American Geriatrics Society·Lisa M Kalisch EllettElizabeth E Roughead
Aug 6, 2014·International Journal of Geriatric Psychiatry·Delia Bishara, Daniel Harwood
Mar 1, 2012·Ophthalmic Epidemiology·Elizabeth E RougheadAndrew L Gilbert
Mar 22, 2014·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Muaed Jamal Alomar
Aug 11, 2016·Artificial Intelligence in Medicine·Tao HoangJiuyong Li
Apr 25, 2018·International Clinical Psychopharmacology·Davide PapolaCorrado Barbui
Mar 2, 2019·Investigative Ophthalmology & Visual Science·Beau J FennerJodhbir S Mehta
Jun 4, 2019·Expert Review of Clinical Pharmacology·Catia Marzolini, Françoise Livio
Jan 1, 2019·Current Epidemiology Reports·Nicole Pratt, Elizabeth Roughead
Nov 9, 2011·The Medical Journal of Australia·Gillian E CaugheyAndrew L Gilbert
Oct 12, 2017·BMC Geriatrics·Nashwa MasnoonGillian E Caughey
Jul 13, 2017·European Journal of Epidemiology·Edward Chia-Cheng LaiJesper Hallas
Jan 14, 2017·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S-H LeeC C Lee
Dec 5, 2020·Scientific Reports·Francisco Torres-BondiaGerard Piñol-Ripoll
Aug 12, 2021·Research in Social & Administrative Pharmacy : RSAP·Earl J MorrisScott M Vouri
Jul 2, 2021·International Journal of Clinical Practice·Chen-Yu WangHorng-Huei Liou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.